IVCC announces monitoring and evaluation system at MIM

October 31, 2009

IVCC will showcase its new Malaria Decision Support System (MDSS) at the 5th Pan-African Multilateral Initiative on Malaria (MIM) conference in Nairobi, Kenya, 1-6 November 2009. A symposium a symposium to disseminate the latest advances in monitoring and evaluation of vector control programmes will also be held.

The MDSS, being demonstrated on IVCC's stand in the exhibition area, is a best practice, continuous surveillance system that integrates monitoring and evaluation data from a malaria control programme and presents it in a web-based, real time geographic format to assist with intervention planning. The system is in final development but an interactive screencast will demonstrate the main features and functionality to delegates. Copies of the screencast will be available for delegates to take away and trial on their own computers.

The stand will be staffed with key project advisors who will be able to explain and discuss the benefits of MDSS and our other monitoring and evaluation systems and analytical tools, including: The stand will also carry details of our developing portfolio of public health pesticide projects to discover new Active Ingredients and new and repurposed formulations, in partnership with the major agrochemical companies. Key project advisors will be on hand to discuss these projects in more detail.

Tom McLean, IVCC's Chief Operating Officer, said: "MIM is the ideal opportunity for us to announce our monitoring and evaluation tools, bringing together as it does the key enablers and users of vector control programmes in Africa".

The symposium, on Tuesday 3 November, will bring together four experts in monitoring and evaluation, chaired by IVCC's Chief Executive Officer, Professor Janet Hemingway. Jacob Williams, Themba Mzilahowa, Anna Winters and Immo Kleinschmidt will present abstracts on various aspects of monitoring and evaluation of vector control.
-end-


Liverpool School of Tropical Medicine

Related Malaria Articles from Brightsurf:

Clocking in with malaria parasites
Discovery of a malaria parasite's internal clock could lead to new treatment strategies.

Breakthrough in malaria research
An international scientific consortium led by the cell biologists Volker Heussler from the University of Bern and Oliver Billker from the UmeƄ University in Sweden has for the first time systematically investigated the genome of the malaria parasite Plasmodium throughout its life cycle in a large-scale experiment.

Scientists close in on malaria vaccine
Scientists have taken another big step forward towards developing a vaccine that's effective against the most severe forms of malaria.

New tool in fight against malaria
Modifying a class of molecules originally developed to treat the skin disease psoriasis could lead to a new malaria drug that is effective against malaria parasites resistant to currently available drugs.

Malaria expert warns of need for malaria drug to treat severe cases in US
The US each year sees more than 1,500 cases of malaria, and currently there is limited access to an intravenously administered (IV) drug needed for the more serious cases.

Monkey malaria breakthrough offers cure for relapsing malaria
A breakthrough in monkey malaria research by two University of Otago scientists could help scientists diagnose and treat a relapsing form of human malaria.

Getting to zero malaria cases in zanzibar
New research led by the Johns Hopkins Center for Communication Programs, Ifakara Health Institute and the Zanzibar Malaria Elimination Program suggests that a better understanding of human behavior at night -- when malaria mosquitoes are biting -- could be key to preventing lingering cases.

Widely used malaria treatment to prevent malaria in pregnant women
A global team of researchers, led by a research team at the Liverpool School of Tropical Medicine (LSTM), are calling for a review of drug-based strategies used to prevent malaria infections in pregnant women, in areas where there is widespread resistance to existing antimalarial medicines.

Protection against Malaria: A matter of balance
A balanced production of pro and anti-inflammatory cytokines at two years of age protects against clinical malaria in early childhood, according to a study led by ISGlobal, an institution supported by ''la Caixa'' Foundation.

The math of malaria
A new mathematical model for malaria shows how competition between parasite strains within a human host reduces the odds of drug resistance developing in a high-transmission setting.

Read More: Malaria News and Malaria Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.